Mark Dudman serves as the Chairman of the Board of Advisors at BrainVivo, collaborating with leading computational neuroscientists to advance innovative technology in the market. Additionally, Dudman is an Early Stage Investor, Board Member, and Advisor at Sierra Venture Partners, where involvement focuses on companies pioneering market-shaping technologies. Prior roles include General Manager and Vice President of Global Product & AI Development at IBM, contributing to IBM Watson Health’s mission to tackle significant health challenges through cognitive insights, and serving as President of Product Operations at NANTHEALTH, which emphasizes personalized healthcare in cancer treatment. Dudman also played a role as an Advisory Board Member for MassTLC, supporting technology development initiatives. Education credentials include a Bachelor of Science in Computer Science from the Rochester Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices